Ali Ardakani

Founder & Managing Director


Novateur Advisor Since



Operations & Business Development


Therapeutics, Devices, COVID-19, Drug & Device Combination, Licensing and M&A, Orphan Drugs, Project Management

“Our mission is to ensure promising life science inventions get access to the best possible advice, are developed properly and reach patients worldwide."

Ali Ardakani
Founder & Managing Director

Ali Ardakani is a technical and entrepreneurial corporate development and operations biotech executive with over 20 years of experience in managing life science projects and companies. His experience includes managing R&D projects in the areas of oncology, respiratory, infectious disease, CNS therapeutics and medical devices, as well as fundraising, licensing and M&A.

Ali is the Founder & Managing Director of Novateur Ventures. Until recently he was Senior Vice President Device & Business Development for Beyond Air (NASDAQ:XAIR), where he was involved with the company from early stage until Nasdaq public offering and several rounds of financing and licensing. He is the CEO and co-founder of Optigo Biotherapeutics, an ophthalmology R&D company, the Chair of the Board of Directors of Life Sciences British Columbia, and Entrepreneur in Residence at Innovate Calgary. He is also an Associate at Creative Destruction Lab. 

To date, Ali has taken several projects from concept to FDA approval, including several 510(k)s, PMA  for medical devices and several FDA INDs. He has also worked on commercialization and pharma partnerships, as well as several global mergers and acquisitions.

Novateur Newsletter

Subscribe to our newsletter for access to latest updates.

Resource Databases

Access Novateur news as well as FDA and Expert Databases.

Relevant Events

Check out conferences and events we are attending!